Wall Street Zen Downgrades Celsius (NASDAQ:CELH) to Hold

Celsius (NASDAQ:CELH) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Sunday.

Several other research firms have also issued reports on CELH. B. Riley reaffirmed a “buy” rating and issued a $56.00 target price (up from $52.00) on shares of Celsius in a report on Friday, August 8th. Bank of America upped their target price on Celsius from $35.00 to $40.00 and gave the company an “underperform” rating in a report on Friday, August 8th. Wells Fargo & Company upped their target price on Celsius from $44.00 to $45.00 and gave the company an “overweight” rating in a report on Wednesday, June 4th. Citigroup reaffirmed a “buy” rating and issued a $60.00 target price (up from $55.00) on shares of Celsius in a report on Friday, August 8th. Finally, Morgan Stanley upped their target price on Celsius from $42.00 to $56.00 and gave the company an “equal weight” rating in a report on Friday, August 8th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $52.28.

Celsius Stock Performance

Shares of CELH opened at $57.30 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 2.11. The stock has a 50 day moving average price of $46.13 and a two-hundred day moving average price of $37.19. The firm has a market capitalization of $14.78 billion, a P/E ratio of 154.86, a P/E/G ratio of 1.31 and a beta of 1.40. Celsius has a 52 week low of $21.10 and a 52 week high of $57.79.

Celsius (NASDAQ:CELH) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.47 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.24. The firm had revenue of $739.30 million during the quarter, compared to analyst estimates of $632.13 million. Celsius had a return on equity of 36.88% and a net margin of 7.91%. The company’s revenue for the quarter was up 83.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.28 EPS. Equities analysts forecast that Celsius will post 0.89 earnings per share for the current fiscal year.

Insider Transactions at Celsius

In related news, CFO Jarrod Langhans sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $51.18, for a total value of $255,900.00. Following the transaction, the chief financial officer owned 109,227 shares in the company, valued at approximately $5,590,237.86. This represents a 4.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder William H. Milmoe sold 300,000 shares of the stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $47.27, for a total value of $14,181,000.00. Following the sale, the insider owned 18,017,770 shares in the company, valued at approximately $851,699,987.90. This represents a 1.64% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,111,141 shares of company stock worth $52,241,605 in the last ninety days. Company insiders own 2.55% of the company’s stock.

Institutional Investors Weigh In On Celsius

Several institutional investors have recently made changes to their positions in CELH. Alliancebernstein L.P. lifted its position in shares of Celsius by 26.3% during the first quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company’s stock worth $642,769,000 after acquiring an additional 3,753,055 shares in the last quarter. Alyeska Investment Group L.P. lifted its position in shares of Celsius by 60.5% during the fourth quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company’s stock worth $181,164,000 after acquiring an additional 2,591,345 shares in the last quarter. Scopus Asset Management L.P. purchased a new stake in shares of Celsius during the second quarter worth $59,382,000. Ilex Capital Partners UK LLP purchased a new stake in shares of Celsius during the second quarter worth $55,966,000. Finally, Holocene Advisors LP lifted its position in shares of Celsius by 130.6% during the second quarter. Holocene Advisors LP now owns 2,108,041 shares of the company’s stock worth $97,792,000 after acquiring an additional 1,193,707 shares in the last quarter. Hedge funds and other institutional investors own 60.95% of the company’s stock.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.